Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial.

Autor: Isa F; Regeneron Pharmaceuticals, Tarrytown, NY, USA. Electronic address: flonza.isa@regeneron.com., Gonzalez Ortiz AM; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Meyer J; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Hamilton JD; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Olenchock BA; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Brackin T; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Ganguly S; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Forleo-Neto E; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Faria L; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Heirman I; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Marovich M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Hutter J; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Polakowski L; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Irvin SC; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Thakur M; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Hooper AT; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Baum A; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Petro CD; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Fakih FA; Clinical Site Partners, d/b/a CSP Orlando, Winter Park, FL, USA., McElrath MJ; Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA., De Rosa SC; Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA., Cohen KW; Fred Hutchinson Cancer Center, Seattle, WA, USA., Williams LD; Duke University School of Medicine, Durham, NC, USA., Hellman CA; Duke University School of Medicine, Durham, NC, USA., Odeh AJ; Duke University School of Medicine, Durham, NC, USA., Patel AH; Duke University School of Medicine, Durham, NC, USA., Tomaras GD; Duke University School of Medicine, Durham, NC, USA., Geba GP; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Kyratsous CA; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Musser B; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Yancopoulos GD; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Herman GA; Regeneron Pharmaceuticals, Tarrytown, NY, USA.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Jan; Vol. 25 (1), pp. 52-67. Date of Electronic Publication: 2024 Sep 02.